XOMA XOMA Corporation Stock Quote

XOMA [NASD]

Index	-	P/E	31.87	EPS (ttm)	0.54	Insider Own	0.20%	Shs Outstand	11.33M	Perf Week	-9.99%
Market Cap	208.24M	Forward P/E	-	EPS next Y	-0.02	Insider Trans	-73.74%	Shs Float	10.81M	Perf Month	-33.01%
Income	12.20M	PEG	1.68	EPS next Q	-0.10	Inst Own	60.10%	Short Float	3.47%	Perf Quarter	-12.77%
Sales	40.90M	P/S	5.09	EPS this Y	-16.60%	Inst Trans	-0.56%	Short Ratio	11.61	Perf Half Y	-33.29%
Book/sh	12.35	P/B	1.39	EPS next Y	-122.50%	ROA	8.30%	Target Price	62.50	Perf Year	-42.48%
Cash/sh	7.30	P/C	2.36	EPS next 5Y	19.00%	ROE	9.60%	52W Range	16.96 - 39.02	Perf YTD	-17.46%
Dividend	-	P/FCF	9.21	EPS past 5Y	15.70%	ROI	12.10%	52W High	-55.38%	Beta	1.09
Dividend %	-	Quick Ratio	11.40	Sales past 5Y	47.00%	Gross Margin	-	52W Low	2.65%	ATR	1.77
Employees	12	Current Ratio	11.40	Sales Q/Q	675.00%	Oper. Margin	52.60%	RSI (14)	34.03	Volatility	9.78% 8.41%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	54.20%	Profit Margin	29.90%	Rel Volume	0.94	Prev Close	17.21
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	0.00%	Avg Volume	32.35K	Price	17.41
Recom	2.30	SMA20	-14.39%	SMA50	-27.74%	SMA200	-27.60%	Volume	12,511	Change	1.16%

Sep-07-21

Downgrade

Wedbush

Outperform → Neutral

$22

Jun-29-21

Initiated

Aegis Capital

Buy

$60

Jan-19-21

Reiterated

H.C. Wainwright

Buy

$30 → $56

Jan-18-18

Reiterated

H.C. Wainwright

Buy

$38 → $49

Oct-17-17

Resumed

H.C. Wainwright

Buy

$38

Sep-05-17

Upgrade

Wedbush

Neutral → Outperform

$9 → $19

Jun-12-17

Initiated

H.C. Wainwright

Buy

$15

Nov-14-16

Downgrade

Wedbush

Outperform → Neutral

$17 → $14

Mar-11-16

Reiterated

Wedbush

Outperform

$6 → $3

Jul-23-15

Downgrade

Jefferies

Buy → Hold

Jul-22-15

Downgrade

Piper Jaffray

Overweight → Neutral

Jul-22-15

Downgrade

Ladenburg Thalmann

Buy → Neutral

Oct-10-14

Resumed

ROTH Capital

Buy

Apr-29-14

Upgrade

MLV & Co

Hold → Buy

Mar-11-14

Downgrade

MLV & Co

Buy → Hold

$8 → $7

Mar-05-14

Reiterated

Ladenburg Thalmann

Buy

$6.50 → $10

Oct-31-13

Reiterated

MLV & Co

Buy

$7.50 → $8

May-09-13

Reiterated

Ladenburg Thalmann

Buy

$5 → $6

May-14-12

Initiated

Cowen & Co

Outperform

Mar-31-11

Reiterated

MLV Capital

Buy

$12 → $10

May-07-22 08:27AM	This Just In: Analysts Are Boosting Their XOMA Corporation (NASDAQ:XOMA) Outlook for This Year Simply Wall St.
May-05-22 08:55AM	Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events GlobeNewswire
May-03-22 08:15AM	Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates Zacks
Apr-20-22 08:24AM	What Is The Ownership Structure Like For XOMA Corporation (NASDAQ:XOMA)? Simply Wall St.
Mar-21-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Mar-15-22 06:21AM	XOMA Corporation's (NASDAQ:XOMA) 32% Share Price Surge Not Quite Adding Up Simply Wall St.
Mar-10-22 09:43AM	XOMA Corporation (NASDAQ:XOMA) Shares Could Be 20% Below Their Intrinsic Value Estimate Simply Wall St.
07:30AM	XOMA to Present at Oppenheimers 32nd Annual Healthcare Conference GlobeNewswire
Mar-08-22 07:30AM	XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire +11.47%
Mar-01-22 07:30AM	XOMA to Present at the 42nd Annual Cowen Health Care Conference GlobeNewswire
Feb-17-22 07:30AM	XOMA to Present at Aegis Capital Corp Investor Conference GlobeNewswire
Jan-21-22 10:21AM	XOMA's (NASDAQ:XOMA) investors will be pleased with their massive 368% return over the last five years Simply Wall St.
Dec-23-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Dec-21-21 07:30AM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire +7.94%
Dec-16-21 07:30AM	XOMA Announces Evolution of Company Leadership and Succession Planning GlobeNewswire
Nov-22-21 11:46AM	Should Weakness in XOMA Corporation's (NASDAQ:XOMA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? Simply Wall St.
Nov-15-21 06:01AM	10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Nov-04-21 10:15AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:40AM	XOMA Earns $35 Million Milestone Payment as Anti-TGF Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer GlobeNewswire
07:30AM	XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire
Oct-28-21 03:06PM	Will Xoma (XOMA) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-27-21 04:50AM	10 Pharma Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Oct-14-21 06:57AM	10 Pharmaceutical Stocks to Buy According to Timothy Lynchs Stonepine Capital Insider Monkey
Oct-08-21 03:35AM	Strength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength? Zacks +8.96%
Sep-22-21 07:30AM	XOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire
Sep-21-21 12:33PM	Here's What XOMA Corporation's (NASDAQ:XOMA) Shareholder Ownership Structure Looks Like Simply Wall St.
Sep-20-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire -6.94%
Sep-13-21 07:30AM	XOMA to Present at H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Sep-07-21 01:49PM	Why Did Wedbush Downgrade Xoma? Benzinga -12.53%
Aug-10-21 04:35PM	XOMA Announces Heather L. Franklin Joins its Board of Directors GlobeNewswire
Aug-05-21 08:45AM	Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire
Jul-29-21 03:05PM	Earnings Preview: Xoma (XOMA) Q2 Earnings Expected to Decline Zacks -5.18%
Jul-28-21 07:30AM	U.S. Food and Drug Administration has Granted Orphan Drug Designation to XOMAs Licensed anti-TGF Asset NIS793 GlobeNewswire
Jul-15-21 06:38AM	XOMA Buys Royalty, Milestone Interest In Checkmate's Vidutolimod From Kuros Biosciences Benzinga
04:17AM	Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuross license agreement with Checkmate Pharmaceuticals GlobeNewswire
04:00AM	XOMA Acquires Royalty and Milestone Interest in Checkmates Vidutolimod (CMP-001) from Kuros Biosciences GlobeNewswire
Jun-23-21 03:16PM	Is XOMA Corp (XOMA) A Good Stock To Buy? Insider Monkey
Jun-21-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Jun-08-21 10:38AM	XOMA Corporation (NASDAQ:XOMA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? Simply Wall St.
May-21-21 08:00AM	XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting GlobeNewswire
May-06-21 09:15AM	Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates Zacks -8.73%
07:30AM	XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire
May-03-21 07:30AM	XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program GlobeNewswire
Apr-15-21 09:05AM	XOMAs Royalty Portfolio Grows with Addition of Three Royalty Assets GlobeNewswire
Apr-12-21 07:30AM	XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters Option GlobeNewswire
Apr-06-21 07:02PM	XOMA Prices $35 Million Offering of Depositary Shares GlobeNewswire
Apr-05-21 04:05PM	XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock GlobeNewswire
Mar-23-21 08:00AM	Viracta and XOMA Announce Multi-License Milestone and Royalty Monetization Transaction PR Newswire
Mar-22-21 07:30AM	XOMA Announces Approval of First Preferred Stock Dividend GlobeNewswire
Mar-10-21 08:45AM	Xoma (XOMA) Beats Q4 Earnings and Revenue Estimates Zacks
07:30AM	XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights GlobeNewswire
Mar-03-21 05:16AM	What Type Of Shareholders Own The Most Number of XOMA Corporation (NASDAQ:XOMA) Shares? Simply Wall St.
Mar-02-21 12:30PM	Xoma (XOMA) to Report Q4 Results: Wall Street Expects Earnings Growth Zacks
Feb-23-21 04:05PM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire
Jan-04-21 04:05PM	XOMA to Present at H.C. Wainwright Virtual BioConnect 2021 and Biotech Showcase Digital Conferences GlobeNewswire -9.77%
Dec-30-20 05:50AM	What Does XOMA's (NASDAQ:XOMA) CEO Pay Reveal? Simply Wall St.
Dec-21-20 05:00PM	XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering GlobeNewswire
Dec-10-20 11:45PM	Is XOMA A Good Stock To Buy Now? Insider Monkey +6.66%
06:22PM	XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock GlobeNewswire
07:52AM	XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock GlobeNewswire
Dec-08-20 08:38AM	XOMA Catches Eye: Stock Jumps 7.9% Zacks
Nov-16-20 07:30AM	XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development GlobeNewswire +11.43%
Nov-12-20 09:47AM	Can You Imagine How XOMA's (NASDAQ:XOMA) Shareholders Feel About The 12% Share Price Increase? Simply Wall St.
Nov-11-20 07:30AM	XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement GlobeNewswire
Nov-06-20 08:56AM	XOMA's Shares March Higher, Can It Continue? Zacks
Nov-05-20 09:35AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Highlights Recent Royalty Asset Portfolio Developments and Reports Third Quarter 2020 Financial Results GlobeNewswire
Nov-03-20 07:30AM	XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi GroupBioasis Strategic Alliance GlobeNewswire +8.24%
Oct-28-20 07:30AM	XOMA Earns $25 Million Milestone Payment as Anti-TGF Antibody Enters Phase 2 Clinical Study in Metastatic Pancreatic Cancer GlobeNewswire
Oct-14-20 07:30AM	XOMA Earns $1.9 Million Associated with Two Partner Developments GlobeNewswire
Sep-23-20 12:15PM	Is XOMA Corporation (NASDAQ:XOMA) Popular Amongst Institutions? Simply Wall St.
Sep-10-20 11:18AM	Insider Buys XOMA's Shares Benzinga
Sep-02-20 07:30AM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire
Aug-17-20 07:19AM	XOMA's Shares March Higher, Can It Continue? Zacks
Aug-06-20 07:50PM	Xoma (XOMA) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:05PM	XOMA Reports Second Quarter 2020 Financial Results GlobeNewswire
Aug-05-20 07:30AM	XOMA to Present at the 2020 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-28-20 12:33PM	Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-01-20 07:30AM	XOMA Announces Natasha Hernday Joins its Board of Directors GlobeNewswire
Jun-29-20 07:30AM	XOMA Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire -6.22%
Jun-24-20 11:00PM	XOMA (XOMA) Catches Eye: Stock Jumps 5.2% Zacks
Jun-22-20 01:58PM	Hedge Funds Are Souring On XOMA Corp (XOMA) Insider Monkey
May-11-20 01:42PM	Things Look Grim For XOMA Corporation (NASDAQ:XOMA) After Today's Downgrade Simply Wall St. +6.92%
May-05-20 09:45AM	Xoma (XOMA) Reports Q1 Loss, Lags Revenue Estimates Zacks
07:30AM	XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update GlobeNewswire
Apr-28-20 12:39PM	Health Check: How Prudently Does XOMA (NASDAQ:XOMA) Use Debt? Simply Wall St. +5.37%
Apr-27-20 12:31PM	Earnings Preview: Xoma (XOMA) Q1 Earnings Expected to Decline Zacks
Mar-13-20 10:53AM	Can You Imagine How Chuffed XOMA's (NASDAQ:XOMA) Shareholders Feel About Its 215% Share Price Gain? Simply Wall St. +11.81%
Mar-10-20 07:30AM	XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights GlobeNewswire -6.23%
Mar-09-20 05:00AM	Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement GlobeNewswire -5.74%
Feb-27-20 12:30PM	Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks
Feb-25-20 04:30PM	XOMA to Present at the Cowen and Company 40th Annual Health Care Conference GlobeNewswire
Jan-22-20 01:02PM	Before You Buy XOMA Corporation (NASDAQ:XOMA), Consider Its Volatility Simply Wall St.
Dec-26-19 07:12AM	Will XOMA Continue to Surge Higher? Zacks
Dec-23-19 04:00PM	Should You Avoid XOMA Corp (XOMA)? Insider Monkey +13.39%
Dec-20-19 04:35PM	XOMA Announces Closing of Rights Offering GlobeNewswire
Dec-16-19 09:34AM	5 Biotech Stocks Set for Continued Rally in 2020 Zacks
Dec-05-19 05:04PM	Iscalimab (CFZ533) Update GlobeNewswire

XOMA Corporation, a biotechnology royalty aggregator, engages in helping biotech companies for improving human health. The company acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. It acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance internal drug candidate or for general corporate purposes. The company has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BURNS THOMAS M.	SVP, Finance & CFO	Mar 23	Option Exercise	4.03	161	649	6,716	Mar 23 06:52 PM
Neal James R	CEO	Mar 23	Option Exercise	4.03	1,111	4,477	12,933	Mar 23 06:52 PM
Neal James R	CEO	Mar 23	Sale	30.02	1,111	33,348	11,822	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 23	Sale	30.00	161	4,830	6,555	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 22	Option Exercise	4.03	2,339	9,426	8,894	Mar 23 06:52 PM
Neal James R	CEO	Mar 22	Option Exercise	4.03	2,339	9,426	14,161	Mar 23 06:52 PM
Neal James R	CEO	Mar 22	Sale	30.02	2,339	70,209	11,822	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 22	Sale	30.02	2,339	70,209	6,555	Mar 23 06:52 PM
Neal James R	CEO	Mar 21	Option Exercise	4.03	50,000	201,500	61,822	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 21	Option Exercise	4.03	12,000	48,360	18,555	Mar 23 06:52 PM
Neal James R	CEO	Mar 21	Sale	29.00	50,000	1,450,250	11,822	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 21	Sale	29.00	12,000	348,060	6,555	Mar 23 06:52 PM
Neal James R	CEO	Jun 25	Sale	33.62	9,027	303,474	11,822	Jun 29 05:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience